Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
GOSSGossamer Bio, Inc.
| Figure | GOSSGossamer Bio, Inc.FY2025 · Dec |
|---|---|
| Revenue | $48.47M |
| Revenue, yoy | −57.7% |
| Net income | $170.37M |
| Net income, yoy | −201.4% |
| Net margin | -351.5% |
| Free cash flow | $171.35M |
| FCF margin | -353.5% |
| EPS, diluted | $0.75 |
Add another company.
Annual · FY2022–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed